SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005827
Filing Date
2014-08-14
Accepted
2014-08-14 11:47:59
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0614_yewbio.htm 10-Q 604771
2 CERTIFICATION f10q0614ex31i_yewbio.htm EX-31.1 10110
3 CERTIFICATION f10q0614ex31ii_yewbio.htm EX-31.2 10067
4 CERTIFICATION f10q0614ex32_yewbio.htm EX-32 5689
  Complete submission text file 0001213900-14-005827.txt   4763549

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20140630.xml EX-101.INS 693253
6 XBRL SCHEMA FILE yewb-20140630.xsd EX-101.SCH 54275
7 XBRL CALCULATION FILE yewb-20140630_cal.xml EX-101.CAL 38442
8 XBRL DEFINITION FILE yewb-20140630_def.xml EX-101.DEF 87808
9 XBRL LABEL FILE yewb-20140630_lab.xml EX-101.LAB 381902
10 XBRL PRESENTATION FILE yewb-20140630_pre.xml EX-101.PRE 231479
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 141040692
SIC: 0100 Agricultural Production-Crops